Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Sucrose octaacetate first caught the attention of chemists in the late 19th century during a period of rigorous experimentation with sugar derivatives. At that time, scientists explored ways to modify naturally occurring molecules for enhanced stability and new functions. Early studies revealed that by treating sucrose with acetic anhydride, a highly bitter compound formed, standing apart from the sweet origin. Commercial production began as researchers realized the substance could serve as a denaturant, leveraging its intense bitterness to prevent accidental ingestion of toxic or industrial materials. In the decades that followed, roles expanded to include pharmaceutical and food safety applications. From patent filings to regulatory studies, sucrose octaacetate’s record shows genuine scientific curiosity transforming into established industry practice. Regulatory frameworks in Europe (EP), Britain (BP), and the US (USP) codified quality standards, pushing the compound into the stricter environment of pharmaceutical manufacturing.
Sucrose octaacetate carries a reputation as one of the most bitter substances known—an odd fate for a sugar derivative. Its crystalline, off-white appearance runs counter to the expectation set by table sugar. Manufacturers sell it in powder or granular form, focusing on purity and consistency to satisfy pharmaceutical buyers. BP, EP, and USP grades answer to strict parameters, supporting medicinal and industrial supply chains where precise characterization matters. Manufacturers invest heavily in analytical equipment—think HPLC, GC-MS, and FTIR spectroscopy—to confirm every batch matches regulatory monographs for purity, moisture, solubility and impurities. Lot traceability, batch records, and verification checks keep the supply chain compliant with international standards, reflecting years of audit experience and the close scrutiny the product regularly receives.
Sucrose octaacetate’s structure features eight acetate groups attached to all available hydroxyl sites, yielding a molecular weight of 518.47 g/mol. This dense acetylation makes the molecule highly hydrophobic with low water solubility but good solubility in organic solvents like chloroform and ethanol. Its melting range usually lands between 83 and 86°C. What stands out is the intense, persistent bitterness. Once tasted, the aversive quality sticks—by design—for taste masking and denaturing uses. A high boiling point and thermal stability make it suitable for formulations that undergo heat during processing. Chemical assays confirm consistently low levels of free acetic acid, chloride, and heavy metals—critical for pharmaceutical adoption and regulatory acceptance.
Every pharmaceutical grade batch tells a story of detailed regulation. Technical specification sheets spell out purity minimums, water content limits, pH ranges, residual solvents, and specific optical rotation, aligning with BP, EP, and USP monographs. Manufacturers test for contaminants such as lead, arsenic, and iron, and many include certificates of analysis reflecting microbial counts to prove the powder’s hygiene. Labeling mandates grow complex in the pharma world—product name, weight, batch code, manufacturing and expiry dates, storage conditions, and regulatory compliance marks all populate the packaging. International shipments call for transport stability studies to assure product quality whether the shipment travels by sea, land, or air. Each container requires tamper-evident seals to prevent adulteration in transit, supporting a supply chain that leaves no detail to chance.
Technicians produce sucrose octaacetate through exhaustive acetylation of sucrose. The process unfolds by warming sucrose with acetic anhydride, catalyzed by strong acids like sulfuric acid. The reaction swaps all hydroxyl groups with acetates, releasing heat, which must be managed to protect both yield and operator safety. After the reaction ends, workup steps remove residual reactants; multiple washings with cold water help purge sulfuric acid and acetic acid byproducts. Recrystallization from ethanol or ethyl acetate polishes the raw product, yielding large, pure crystals that can be milled to specification. The synthetic route seems simple in principle, but scale-up for pharma-grade production demands sharp control. Quality managers track every variable—reaction time, stirring speed, temperature, purity of incoming chemicals—since process deviations swiftly impact product compliance.
Among potential chemical tweaks, hydrolysis stands as the main path for modifying sucrose octaacetate, enabling conversion back to partially or fully de-acetylated derivatives. In the lab, alkaline conditions strip acetate groups, giving chemists a route to modify the compound’s bitterness or physical properties. This flexibility lets formulation scientists fine-tune taste masking capacity or chemical compatibility for different actives. Sucrose octaacetate itself remains unreactive toward many pharmaceuticals, making it a passive carrier. Some teams investigate grafting additional groups onto the already-acetylated skeleton, but the bulkiness of the core constrains large structural changes. It’s impressive how a seemingly mundane sugar can pave the way for creative chemical innovation, yet its main successes come from leaving the structure largely untouched.
Buyers searching supplier catalogs find this molecule under several names—sucrose octaacetate, saccharose octaacetate, or 1,2,3,3’,4,6,6’-heptaacetyl-β-D-fructofuranosyl-1’,2’,3’,4’,6’-pentaacetyl-α-D-glucopyranoside. International suppliers and regulatory documents reference its CAS number: 126-14-7. Over time, some packages arrive labeled “SOA Pharma Grade” or “BP/USP/EP Sucrose Octaacetate,” reflecting the standard to which they comply. Regardless of the name, buyers hunt for the same robust analytical information: purity, assay, and compliance with their local pharmacopeial guidelines.
Safe handling demands protective gloves, goggles, and lab coats, echoing chemical industry best practices accredited by ISO and GMP certifications. Workers moving large volumes risk exposure to fine dust, so facilities invest in dust extraction and air monitoring. Inhalation invokes nausea, reinforcing the importance of local exhaust ventilation and controlled powder transfers. Storage guidelines urge dry, cool environments to stave off hydrolytic degradation. Waste streams carrying acetylated byproducts run through neutralization units before discharge, meeting environmental compliance. Employee training drills safety attitudes deep, given the daily work involves highly bitter, potentially irritating powders. Emergency plans for eye or skin contact center on rapid rinsing and medical assessment by occupational health teams.
Sucrose octaacetate works as a denaturant in medicinal alcohols, helping prevent accidental or intentional ingestion. In pharmaceutical tablets and syrups, just microgram concentrations reliably mask the natural sweetness or bitterness of actives, letting medicines taste truly awful so tampering or accidental overdose becomes less likely. Some dental care products use it to discourage thumb sucking or nail biting in children—a testament to the profound aversion the compound can trigger. Beyond those uses, the molecule acts as a research tool in sensory panels or taste masking studies. In industrial settings, employees find it in coatings for wires and furniture edges to ward off rodents and pests, showing its reach beyond the pharmacy shelf.
University labs and industry R&D departments regularly explore avenues to unlock new uses for sucrose octaacetate. Analytical chemists study formulations to assess its interactions with other excipients and active pharmaceutical ingredients, focusing on taste masking and stability. Process engineers continually look at scalable production tweaks to reduce solvent use, cut energy consumption, and shrink the environmental footprint. Academic projects investigate prodrug conjugates where sucrose octaacetate links to active molecules, seeking to alter dissolution, absorption, or taste. International conferences and peer-reviewed papers document advances, and every year patent filings signal the ongoing search for technological edges. Teams with pharmacology expertise monitor how minute concentrations impact oral tolerability and patient compliance in sensitive populations.
Scientists have examined the acute and chronic toxicity profile of sucrose octaacetate, profiling its aversive properties and systemic effects. Animal studies, including those by the World Health Organization and national toxicology programs, show low systemic absorption and rapid elimination in mammals. Repeated oral intake in rats and dogs does not result in mutagenicity or organ toxicity at realistic exposure levels. In rare human cases, exposure above recommended thresholds provokes mild gastrointestinal symptoms—nausea, vomiting, or diarrhea—but these reports stem from accidents or intentional misuse, not pharmaceutical application. Toxicology panels note a high safety margin, making the molecule ideal for tasks involving childproofing, denaturing, or aversion therapy. Regulators in the US and Europe consistently class it as non-carcinogenic and safe for use under prescribed limits.
Looking ahead, sucrose octaacetate faces growing demand in both established and emerging pharmaceutical markets. As regulatory bodies push for safer excipient profiles and robust taste masking in pediatric formulations, scientists keep tuning its performance and application. New studies use AI-driven modeling and machine learning to predict its compatibility with other excipients, formulation matrices, and patient populations. Green chemistry teams invest in alternative acetylation routes using renewable solvents and decreased catalyst loads. Applications in addiction medicine and aversion therapy suggest a role far beyond flavor masking—think deterrence of ingestion for prescription opioids or deterrent coatings for household cleaners. Patent activity hovers at a healthy pace as startups and generics manufacturers jockey for lower-cost synthesis and improved safety profiles. In product management meetings, decision makers weigh how to optimize procurement, compliance, and supply risk in the face of shifting global regulations and customer needs.
Most people don’t give much thought to the strange-sounding additives tucked into medicine and flavoring agents. Sucrose octaacetate pops up as a name that barely rolls off the tongue, yet it carries significance in the pharmaceutical world. I remember walking through a tablet manufacturing line some years ago and watching teams handle a drum marked with its name. Nobody was rushing to sprinkle it into their coffee—that’s for sure. The compound, with its sharp taste, finds a home in several important applications.
Bittering agents protect people, especially children, from swallowing things they shouldn’t touch. Sucrose octaacetate’s primary use in medicines comes from this near-unbearable taste. Drugmakers blend it into products that must stay out of reach: topical ointments, nail-biting deterrents, and some packaging materials. Poison prevention plays a big role here, considering stories of accidental child ingestion. The medical industry learned long ago that a tough-to-swallow flavor saves lives.
It does more than discourage curious taste-testing. I once saw a compounding pharmacist use sucrose octaacetate to make a liquid formulation downright undrinkable. They explained that parents would try everything to stop their toddler from biting their nails—liquid bitterness often put an end to the habit. The story stayed with me, showing how this molecule steps in as silent guardian in family medicine cabinets.
Pharmaceutical-grade sucrose octaacetate, marked BP, EP, USP, follows strict regulations. These standards assure that what lands in a drug bottle meets verified quality and purity. Recognized standards prove vital for patient safety. No corner shop chemistry fits here. Adulterated or contaminated batches risk harm, so audits and inspections back every shipment. Trust grows out of rigorous oversight, not hope or shortcuts.
Pharmacists, regulators, and manufacturers work in concert to make sure the product always matches the promised quality. Labs run repeated batches through testing for impurities. Sucrose octaacetate’s role in public health deserves this care and transparency. The bad taste may seem like a minor detail, but the purity of the compound directly links to its reliability as a guard against accidental ingestion.
Most medication makers want to mask harsh flavors, not highlight them. Sucrose octaacetate serves as a rare exception. Its bitterness grabs attention. Companies design capsules and tablets with extra coatings so the bitterness works only when necessary. Overly bitter medicines risk non-adherence, but this compound’s use proves the value of carefully applied unpleasantness for safety.
A solution to accidental poisoning won't come from better childproof packaging alone. Adding highly bitter compounds remains a strong line of defense. Education also matters—teaching families to recognize warning labels and keep medicines out of reach. Product innovation must go hand-in-hand with community responsibility.
Healthcare relies on more than just the medicine in each pill; it depends on keeping people safe before sickness strikes. By using sucrose octaacetate responsibly and demanding the highest standards, the industry balances effectiveness with safety. Those working in the field learn quickly: sometimes, the strongest protectors wear the bitterest disguises.
Sucrose octaacetate doesn’t pop up in daily conversation, but it plays a distinct role in the pharmaceutical world. In my experience analyzing pharmaceutical ingredients, those in charge of sourcing always want crisp details. For this compound, clarity starts with purity and physical characteristics. You get a crystalline powder, ranging from white to slightly off-white. Solid, no color surprises or strange smells. If a batch carries any odd tint or aroma, it raises immediate red flags in the lab.
Purity isn’t just a mark on a report—it’s the gatekeeper for quality and safety. Pharma grade sucrose octaacetate usually crosses the threshold of 98% purity, and some go over 99%. The rest shouldn’t include anything toxic or unexpected. Any big deviation poses a direct risk to finished medicines. In my lab days, testing always aimed at substances like arsenic, lead, and heavy metals—levels must rest well below a fraction of a part per million. Water content gets attention too—moisture causes trouble for stability. Good suppliers provide a maximum loss on drying close to 0.5%.
A batch’s credentials show up in a standard table that goes like this:
Any pharmaceutical manufacturer who skips careful checks on these points plays a dangerous game. In my years working around API audits, the best teams never just trust supplier paperwork—they send out confirmations with third-party labs.
Most failures I’ve seen in impurity results stem from handling or storage problems. Acetic acid residues, chloride, and sulfate ions stand out on reports. Residual solvents matter, especially if the synthesis uses acetone, methanol, or dichloromethane. The pharmacopoeias clamp down hard on these, since just a few extra parts per million lead to recall risks or regulatory headaches. For global pharma sales, passing both USP and EP impurity cutoffs becomes non-negotiable.
The best evidence comes not only from supplied certificates, but from repeatable, validated test methods. In labs I’ve worked with, infrared spectroscopy, high-performance liquid chromatography, and melting point tests settle most debates about identity and contamination. I’ve watched quality control teams halt production over a tenth of a degree shift in melting point because that can signal unwanted byproducts.
Why sweat small numbers? Because tainted or subpar batches wind up in products intended for people with health problems. Even trace impurities threaten anyone with allergies or compromised immunity. Sourcing managers, QA inspectors, and pharmacists all share the responsibility—documentation, rigorous vendor audits, and cross-check testing build trust at every step.
Every time another batch makes it through all these quality checks, it’s a small relief. Every time the specs come up short, the right call is a hard rejection. At the end of the day, patients deserve nothing less.
Every time someone buys sucrose octaacetate BP EP USP, they expect a solid, stable chemical compound—untouched by light, air, or moisture. The packaging brings more than convenience. Traditionally, manufacturers go for airtight, sealed containers, preferably made from high-density polyethylene (HDPE) or amber glass. These help keep out the elements, and they stop leaching of unwanted substances into the product. Bulk buyers dealing with larger operations typically receive the compound in polyethylene-lined fiber drums, sometimes in the 25 kg to 50 kg range, adding an extra barrier for purity. Those working in labs or with smaller projects often receive glass bottles or smaller plastic containers—anything that closes tightly and turns away stray humidity.
My own years inside research labs showed why these choices matter. The smallest trickle of ambient moisture can ruin a batch, clumping powders and triggering off-flavors, even at low exposure. Once, we saw a batch stored in a simple plastic jug. Weeks later, contamination reared its head—peeling, odd smell, loss of reliability. Lesson learned: short-changing packaging turns small mishaps into lost resources and compromised results.
Manufacturers across the globe indicate a shelf life for sucrose octaacetate—typically ranging from 24 to 36 months—when it sits sealed and untouched by extremes. I’ve seen pharma-grade material stored in ambient warehouses in Mumbai and cold labs in Stockholm; both places stuck to mostly similar timelines. The science lines up here: the compound resists hydrolysis and oxidation decently unless exposed to open air, bright light, or high humidity.
Data from suppliers like Sigma-Aldrich and Thermo Fisher matches this lived reality—shelf life holds if you avoid the classic pitfalls: storing near heat sources, under fluorescent lighting, or leaving containers ajar. I once watched a teaching assistant, eager to cut corners, set chemicals on an open shelf in direct sun. By month’s end, their white powder dulled to yellow, and an off-putting odor crept in—the compound broke down, no doubt about it. These costly errors spell bad science and bigger bills.
In strongly regulated spaces like pharmaceuticals and flavor manufacturing, the packaging and storage protocol often gets audited. Regulators want proof: containers with tamper-evidence, proper batch labeling, source traceability, and, crucially, true-to-form storage instructions. Ignoring such basics threatens not just profits, but end-user safety.
Room temperature usually works—provided it stays away from high humidity and keeps the temperature from climbing above 30°C. Once opened, the clock ticks a little faster. Ideally, labs record open dates and move the contents to smaller vials if frequent access is needed, avoiding the hassle and risk of constantly unsealing the original drum.
A lot of spoilage comes down to two things: careless handling and cheap packaging. If suppliers cut corners or users treat containers as afterthoughts, both lose. Using opaque HDPE drums or amber bottles, always in a dry storage room, stops most issues before they start. Labeling should never be an afterthought—clear expiry and open dates, hazard warnings, and manufacturer info all give traceability.
Switching to sustainable packaging might help in the long run, too. Eco-friendly, moisture-resistant options cut plastic waste without sacrificing chemical integrity. Some leading companies trial biodegradable liners inside sturdy outer drums—a small change, big future impact.
Sucrose octaacetate doesn’t demand miracles, just thoughtful choices in both packaging and daily storage. Routine care, proper labels, and a dry cupboard beat careless shortcuts every time.
Sucrose octaacetate comes up often in conversations around pharmaceutical additives, particularly as a bittering agent and marker in drug formulations. To check if it matches pharmacopeia standards laid out by BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia), we dive into a complex territory. These standards aren’t created for show—they lay out the boundaries for identity, purity, safety, and quality.
Compliance does not come down to a stamp or casual claim. Manufacturers must back up their position with rigorous documentation and testing, often reflected in a Certificate of Analysis. Sucrose octaacetate used in pharmaceutical production sees its identity checked through infrared absorption, melting range, and refractive index. The substance must also pass detailed impurity profiles and residue on ignition standards. Each pharmacopeia spells out target values, so a compliant product keeps those limits in line.
In practice, labs run HPLC assays for content and search for potential toxic by-products. Limit tests keep tabs on heavy metals like lead, microbial contamination, and traces of solvents. I once spent weeks verifying results with my team, because a batch with slightly out-of-spec residue on ignition meant immediate rejection. Pharmacopeial testing expects transparency and precision—not an easy checklist, but a sustained commitment. In my experience, this process catches issues long before they could jump the regulatory fence.
Although BP, EP, and USP each cover sucrose octaacetate, their monographs rarely overlap entirely. One country’s allowable impurity gets flagged as a concern down the road. I’ve watched manufacturers scramble to align batches due to shifts in regional preferences or updates. One European customer insisted on retesting when a previously unnoticed solvent showed up, even below reporting thresholds. The expectation remains: bring the material to meet or exceed the most demanding standard required for its destination.
Pharmaceuticals rely heavily on excipients and additives doing their job quietly, without triggering off-label effects or regulatory headaches. Overlooking a small detail in compliance—an impurity, or a missed microbial test—makes everyone nervous, from the lab technician who did the original assay to the pharmacist dispensing medication. Patients and users expect the same rigorous quality for every batch. Knowing a product follows BP, EP, or USP guidelines acts less like a marketing badge and more like a patient safety net.
Full traceability matters to me, and to most in the industry. Sharing lot records and test methods with customers, looping in all documentation, and investing in staff training—these practices close gaps. Quality inspections sometimes seem like a daily grind, but they chase out surprises. Meeting stringent pharmacopeia standards for sucrose octaacetate doesn’t only protect the end user; it reinforces a system where every link in the supply chain stays accountable. From factory floor to finished product, clarity and careful compliance weave trust.
Anyone who’s spent time in a lab or around pharmaceutical manufacturing tools comes across tongue-twisting substances like Sucrose Octaacetate. This isn’t sugar for your coffee. It’s a bitter-tasting chemical used to coat medicines, mask flavors, and test taste thresholds. Up close, Sucrose Octaacetate looks like white, crystalline powder but don’t let the innocent appearance fool you. Its pharmaceutical grade means it’s purer than what gets tossed around in flavor experiments, and that level of purity demands respect.
People might roll their eyes at “wear your gloves, goggles, and lab coat,” but the message keeps getting drilled into safety training for a reason. Sucrose Octaacetate is not considered highly dangerous, yet direct skin contact feels unpleasant, and powders get everywhere if you’re not careful. Unprotected hands risk irritation, and nobody wants accidental exposure in eyes or on skin. A good pair of nitrile gloves prevents sticky situations. Face shields or at least safety goggles stop dust from blowing up into your eyes, which can sting like crazy.
Powdery chemicals hang in the air longer than most realize. If the workspace doesn’t have strong ventilation or a fume hood, fine particles build up. Breathing in these particles, even for a short time, leads to respiratory discomfort and headaches. I’ve watched careless coworkers deal with throat itch and sneezing fits simply because they skipped the ventilation step or quick-access dust masks. Even pharma-grade compounds can cause a mess if you overlook good airflow practices.
Few things cause more panic in a lab than a broken container of something labeled “pharma grade”. Sucrose Octaacetate needs dry, airtight storage away from anything reactive. Leaving the cap off for even a couple of minutes leads to clumping and spills. Once clumped, it’s almost impossible to measure accurately, which might not just waste money but also lead to dosing errors in a pharmaceutical setting. Keep it tightly sealed, labeled clearly, and out of sunlight. Common sense practices save hours of cleanup and headaches later.
A small spill of Sucrose Octaacetate doesn’t warrant hazmat suits, but quick cleanup matters. Always have spill kits nearby, complete with disposable wipes and a dedicated dustpan/brush to keep residues from spreading. Always wipe the bench, even if nothing is visible. Document every mishap promptly so others in the workplace know what happened. Good record-keeping forms part of laboratory safety culture, not just paperwork for regulators.
Textbook advice doesn’t always prepare you for the small mistakes that happen during a busy day—forgetting to recap a bottle, mixing up gloves, or using habitual shortcuts. Only ongoing training keeps team awareness sharp. Regular check-ins about chemical handling and refresher courses mean fewer “close calls” and less time spent dealing with preventable exposure. Whenever someone skips important steps, the risk increases for everyone in the room. It’s always the little stuff—like not washing hands afterward or carelessly brushing powder off a bench—that adds up over weeks and months.
Looking after yourself and coworkers creates an environment where safety isn’t just for show—it’s part of the routine. Investing time in proper PPE, good airflow, tidy storage, and fast cleanup keeps everyone healthy and the workspace productive. Pharmaceutical manufacturing, research, or teaching labs all benefit from getting these basics right. There’s no shortcut around vigilance when handling fine, pure chemicals like Sucrose Octaacetate.
| Names | |
| Preferred IUPAC name | 1,2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl 1,3,4,6-tetra-O-acetyl-α-D-fructofuranoside |
| Other names |
SUCR Sucrose octaacetate Sucrose, octaacetate Octa-O-acetylsucrose |
| Pronunciation | /ˈsuː.kroʊs ɒk.tə.əˈsiː.teɪt/ |
| Identifiers | |
| CAS Number | 126-14-7 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Sucrose Octaacetate**: ``` C[C@@H]1O[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@H](OC(=O)C)[C@H](OC(=O)C)[C@H]1OC(=O)C ``` This is the **SMILES string** you can use to visualize the 3D structure in JSmol or similar molecular viewers. |
| Beilstein Reference | 1913791 |
| ChEBI | CHEBI:8315 |
| ChEMBL | CHEMBL1356 |
| ChemSpider | 14516 |
| DrugBank | DB11287 |
| ECHA InfoCard | ECHA InfoCard: 03a3ff5a-e2c9-4e83-8cf3-47a1a996a96d |
| EC Number | 205-426-2 |
| Gmelin Reference | 28583 |
| KEGG | C00794 |
| MeSH | D009002 |
| PubChem CID | 9144 |
| RTECS number | WS1900000 |
| UNII | R725T6E68B |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C28H38O19 |
| Molar mass | 626.56 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.40 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | -6.3 |
| Vapor pressure | 0 mmHg (25°C) |
| Acidity (pKa) | 12.1 |
| Basicity (pKb) | pKb ≈ 12.5 |
| Magnetic susceptibility (χ) | -8.2e-6 |
| Refractive index (nD) | 1.485 (20°C) |
| Viscosity | 200 cP |
| Dipole moment | 2.75 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 468.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -2065.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3954 kJ/mol |
| Pharmacology | |
| ATC code | A06AD12 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye irritation. |
| GHS labelling | GHS07, GHS Hazard Statements: H302, H319, GHS Precautionary Statements: P264, P270, P301+P312, P305+P351+P338 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No hazard statements. |
| Precautionary statements | Precautionary statements: P261, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Flash point | 210°C |
| Autoignition temperature | 160°C (320°F) |
| Lethal dose or concentration | LD50 (oral, rat): 1800 mg/kg |
| LD50 (median dose) | LD50 (median dose): 25 g/kg (oral, rat) |
| NIOSH | WF3325000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Sucrose Octaacetate BP EP USP Pharma Grade: "No specific OSHA PEL established |
| REL (Recommended) | 10 mg |
| Related compounds | |
| Related compounds |
Sucrose Glucose pentaacetate Cellulose acetate Sucrose hexaisobutyrate Sucrose laurate Mannitol octaacetate |
Chengguan District, Lanzhou, Gansu, China
